8-K Announcements
6Material company update
May 1, 2026·SEC
Material company update
Apr 30, 2026·SEC
Material company update
Apr 30, 2026·SEC
Ryan Specialty Holdings, Inc.(RYAN)Earnings, Financials & Key Ratios
RYAN•NYSE•Insurance & Managed Care
74.4× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustrySpecialty InsuranceSub-IndustryInsurance Distribution and MGA Services
AboutRyan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company was founded in 2010 and is headquartered in Chicago, Illinois.Show more
- Revenue$3.05B+21.3%
- Combined Ratio79.51%-10.8%
- Net Income$63M-33.0%
- Return on Equity5.39%-40.8%
- Medical Cost Ratio9.42%
- Operating Margin20.49%+89.1%
- Net Margin2.08%-44.8%
- ROA0.63%-44.0%
- Equity / Assets11.87%+4.3%
RYAN Key Insights
Ryan Specialty Holdings, Inc. (RYAN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 79.5% combined ratio
- ✓Low loss ratio of 9.4%
✗Weaknesses
- ✗High debt to equity ratio of 2.8x
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when RYAN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RYAN Price & Volume
Ryan Specialty Holdings, Inc. (RYAN) stock price & volume — 10-year historical chart
Loading chart...
RYAN Growth Metrics
Ryan Specialty Holdings, Inc. (RYAN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years24.54%
3 Years20.93%
TTM18.93%
Profit CAGR
10 Years-
5 Years-1.42%
3 Years1.27%
TTM160.73%
EPS CAGR
10 Years-
5 Years-5.99%
3 Years-3.31%
TTM551.28%
Return on Capital
10 Years4.22%
5 Years3.65%
3 Years4.54%
Last Year6.42%
RYAN Recent Earnings
Ryan Specialty Holdings, Inc. (RYAN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$0.47+9.3%
$0.43
Rev
$795M+1.8%
$781M
Q1 2026
Feb 12, 2026Metric
Actual
Est
EPS
$0.45-10.0%
$0.50
Rev
$751M-3.3%
$777M
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.47+0.0%
$0.47
Rev
$755M-2.9%
$777M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.66+0.0%
$0.66
Rev
$855M+14.7%
$746M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.47vs $0.43+9.3% | $795Mvs $781M+1.8% |
| Q1 2026 | Feb 12, 2026 | $0.45vs $0.50-10.0% | $751Mvs $777M-3.3% |
| Q4 2025 | Oct 30, 2025 | $0.47vs $0.47+0.0% | $755Mvs $777M-2.9% |
| Q3 2025 | Jul 31, 2025 | $0.66vs $0.66+0.0% | $855Mvs $746M+14.7% |
Based on last 12 quarters of dataView full earnings history →
RYAN Peer Comparison
Ryan Specialty Holdings, Inc. (RYAN) competitors in Insurance Distribution and MGA Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 BWIN | 1.52B | 20.24 | -40.48 | 9.35% | -2.81% | -3.77% | 1.63 | |
 ACGL | 32.48B | 91.18 | 7.85 | 14.27% | 22.07% | 19.02% | 0.11 | |
 ERIE | 10.21B | 221.14 | 20.82 | 7.17% | 13.2% | 25.03% | ||
 AON | 68.08B | 317.74 | 18.67 | 9.45% | 22.54% | 44.16% | 1.73 | |
 MMC | 85.27B | 174.06 | 21.28 | 7.57% | 15.6% | 26.87% | 1.62 | |
 WTW | 24.06B | 255.20 | 15.70 | -2.24% | 16.84% | 20.77% | 0.86 | |
 GSHD | 872.97M | 36.88 | 35.46 | 16.15% | 7.94% | |||
 SLQT | 174.25M | 0.99 | 74.32 | 15.5% | 4.45% | 12.16% | 0.72 |
Compare RYAN vs Peers
Ryan Specialty Holdings, Inc. (RYAN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RYAN Income Statement
Ryan Specialty Holdings, Inc. (RYAN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue | 765.11M | 1.02B | 1.43B | 1.73B | 2.08B | 2.52B | 3.05B | 3.16B |
Revenue Growth % | - | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% | 21.28% | 18.93% |
Medical Costs & Claims | 0 | 0 | 0 | 0 | 0 | 0 | 287.51M | 964.31M |
Medical Cost Ratio % | 0% | 0% | 0% | 0% | 0% | 0% | 9.42% | 30.55% |
Gross Profit | 765.11M▲ 0% | 1.02B▲ 33.1% | 1.43B▲ 40.7% | 1.73B▲ 20.4% | 2.08B▲ 20.4% | 2.52B▲ 21.1% | 2.76B▲ 9.9% | 2.19B▲ 0% |
Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 90.58% | 69.45% |
Gross Profit Growth % | - | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% | 9.85% | - |
Operating Expenses | 697.13M | 938.81M | 1.37B | 1.55B | 1.84B | 2.24B | 2.14B | 1.67B |
OpEx / Revenue % | 91.11% | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% | 70.08% | 52.88% |
Depreciation & Amortization | 53.1M | 67.5M | 112.68M | 109.29M | 115.84M | 167.63M | 287.51M | 219.89M |
Combined Ratio % | 91.11% | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% | 79.51% | 83.43% |
Operating Income | 67.98M▲ 0% | 79.47M▲ 16.9% | 61.56M▼ 22.5% | 179.19M▲ 191.1% | 237.93M▲ 32.8% | 272.55M▲ 14.6% | 625.23M▲ 129.4% | 522.87M▲ 0% |
Operating Margin % | 8.89% | 7.8% | 4.3% | 10.39% | 11.45% | 10.83% | 20.49% | 16.57% |
Operating Income Growth % | - | 16.89% | -22.53% | 191.07% | 32.78% | 14.55% | 129.4% | - |
EBITDA | 121.08M | 146.97M | 174.25M | 288.48M | 353.76M | 440.18M | 912.75M | 742.76M |
EBITDA Margin % | 15.83% | 14.43% | 12.16% | 16.72% | 17.03% | 17.5% | 29.92% | 23.53% |
Interest Expense | 35.55M | 47.24M | 79.35M | 104.83M | 119.51M | 158.45M | 222.38M | 221.61M |
Non-Operating Income | -35.55M | -47.24M | -79.35M | -104.83M | -119.51M | -158.45M | 109.66M | 15.94M |
Pretax Income | 67.98M▲ 0% | 79.47M▲ 16.9% | 61.56M▼ 22.5% | 179.19M▲ 191.1% | 237.93M▲ 32.8% | 272.55M▲ 14.6% | 293.18M▲ 7.6% | 289.25M▲ 0% |
Pretax Margin % | 8.89% | 7.8% | 4.3% | 10.39% | 11.45% | 10.83% | 9.61% | 9.16% |
Income Tax | 4.93M | 8.95M | 4.93M | 15.94M | 43.45M | 42.64M | 79.03M | 30.11M |
Effective Tax Rate % | 7.25% | 11.27% | 8.01% | 8.89% | 18.26% | 15.64% | 26.95% | 10.41% |
Net Income | 64.17M▲ 0% | 68.1M▲ 6.1% | 65.87M▼ 3.3% | 61.05M▼ 7.3% | 61.04M▼ 0.0% | 94.67M▲ 55.1% | 63.4M▼ 33.0% | 131.64M▲ 0% |
Net Margin % | 8.39% | 6.69% | 4.6% | 3.54% | 2.94% | 3.76% | 2.08% | 4.17% |
Net Income Growth % | - | 6.14% | -3.28% | -7.32% | -0.02% | 55.09% | -33.03% | 160.73% |
EPS (Diluted) | 0.60▲ 0% | 0.64▲ 6.7% | -0.07▼ 110.9% | 0.52▲ 842.9% | 0.52▲ 0.0% | 0.71▲ 36.5% | 0.47▼ 33.8% | 1.02▲ 0% |
EPS Growth % | - | 6.67% | -110.94% | 842.86% | 0% | 36.54% | -33.8% | 551.28% |
EPS (Basic) | 0.60 | 0.64 | -0.07 | 0.56 | 0.57 | 0.78 | 0.50 | - |
Diluted Shares Outstanding | 106.49M | 106.49M | 105.73M | 265.75M | 125.75M | 274.84M | 278.51M | 129.6M |
RYAN Balance Sheet
Ryan Specialty Holdings, Inc. (RYAN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Assets | 2.19B | 4.53B | 5.46B | 6.38B | 7.25B | 9.65B | 10.56B | 11.01B |
Asset Growth % | - | 106.79% | 20.52% | 16.95% | 13.53% | 33.15% | 9.47% | 65.46% |
Total Investment Assets | 22.52M | 47.22M | 45.42M | 38.51M | 46.1M | 84.81M | 109.98M | 4M |
Long-Term Investments | 22.52M | 47.22M | 45.42M | 38.51M | 46.1M | 70.88M | 109.98M | 424.26M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 13.94M | 0 | 0 |
Total Current Assets | 1.42B | 0 | 3.04B | 3.91B | 4.35B | 4.81B | 647.27M | 5.58B |
Cash & Equivalents | 52.02M | 312.65M | 386.96M | 992.72M | 838.79M | 540.2M | 158.32M | 154.65M |
Receivables | 127.14M | 2.16B | 2.6B | 2.87B | 3.46B | 4.17B | 488.95M | 10.31B |
Other Current Assets | 1.22B | -2.51B | 0 | 0 | 0 | 0 | -76.55M | 4.86B |
Goodwill & Intangibles | 693.75M | 1.83B | 1.88B | 1.8B | 2.26B | 4.12B | 3.34B | 16.16B |
Goodwill | 528.51M | 1.22B | 1.31B | 1.31B | 1.65B | 2.65B | 3.23B | 3.22B |
Intangible Assets | 165.24M | 604.76M | 573.93M | 486.44M | 610.67M | 1.48B | 119.62M | 127.05M |
PP&E (Net) | 11.56M | 111.36M | 100.16M | 175.14M | 170.13M | 183.47M | 199.94M | 191.94M |
Other Assets | 41.26M | -1.99B | 10.79M | 56.99M | 39.31M | 18.59M | 5.95B | 1.47B |
Total Liabilities | 2.13B | 4.46B | 4.86B | 5.57B | 6.27B | 8.55B | 9.31B | 9.79B |
Total Debt | 669.27M | 1.69B | 1.68B | 2.16B | 2.16B | 3.46B | 3.53B | 3.74B |
Net Debt | 617.26M | 1.38B | 1.3B | 1.16B | 1.32B | 2.92B | 3.37B | 3.59B |
Long-Term Debt | 660.03M | 1.57B | 1.57B | 1.95B | 1.94B | 3.23B | 3.29B | 3.68B |
Short-Term Debt | 9.25M | 19.16M | 23.47M | 30.59M | 35.38M | 51.73M | 60.19M | 62.55M |
Total Current Liabilities | 1.43B | 0 | 433.56M | 414.31M | 501.28M | 649.45M | 86.17M | 5.46B |
Accounts Payable | 45.93M | 0 | 0 | 0 | 0 | 0 | 217.3M | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1.22B | -39.04M | 631K | 562K | 55K | 39.92M | -217.3M | 5.39B |
Deferred Taxes | 0 | 577K | 631K | 562K | 55K | 1000K | 1000K | 176.17M |
Other Liabilities | 39.23M | -1.65B | 2.79B | 3.05B | 3.67B | 4.47B | 5.73B | 609.16M |
Total Equity | 63.15M▲ 0% | 71.09M▲ 12.6% | 594.78M▲ 736.7% | 817.81M▲ 37.5% | 979.64M▲ 19.8% | 1.1B▲ 12.1% | 1.25B▲ 14.2% | 1.22B▲ 0% |
Equity Growth % | - | 12.56% | 736.65% | 37.5% | 19.79% | 12.11% | 14.18% | 51.46% |
Shareholders Equity | 64.26M | 69.79M | 343.77M | 478.4M | 559.75M | 627.66M | 648.07M | 636.2M |
Minority Interest | -1.11M | 1.3M | 251M | 339.41M | 419.89M | 470.62M | 605.98M | 582.85M |
Retained Earnings | -173.75M | 0 | -7.06M | 53.99M | 114.42M | 122.94M | 120.35M | 120.53M |
Common Stock | 97.5M | 0 | 259K | 259K | 261K | 261K | 265K | 263K |
Accumulated OCI | 864K | 2.7M | 1.71M | 6.04M | 3.08M | -1.8M | 13.85M | 9.39M |
Return on Equity (ROE) | 101.6% | 101.46% | 19.79% | 8.64% | 6.79% | 9.11% | 5.39% | 10.77% |
Return on Assets (ROA) | 2.93% | 2.03% | 1.32% | 1.03% | 0.9% | 1.12% | 0.63% | 1.25% |
Equity / Assets | 2.88% | 1.57% | 10.9% | 12.81% | 13.52% | 11.38% | 11.87% | 11.07% |
Debt / Equity | 10.60x | 23.76x | 2.83x | 2.64x | 2.20x | 3.15x | 2.82x | 3.07x |
Book Value per Share | 0.59 | 0.67 | 5.63 | 3.08 | 7.79 | 4.00 | 4.50 | 9.41 |
Tangible BV per Share | -5.92 | -16.51 | -12.19 | -3.70 | -10.16 | -11.00 | -7.51 | -16.40 |
RYAN Cash Flow Statement
Ryan Specialty Holdings, Inc. (RYAN) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 149.51M | 135.39M | 273.49M | 335.51M | 477.2M | 514.87M | 643.67M | 619.08M |
Operating CF Growth % | - | -9.44% | 102% | 22.68% | 42.23% | 7.89% | 25.02% | 82.81% |
Operating CF / Revenue % | 19.54% | 13.3% | 19.09% | 19.45% | 22.97% | 20.47% | 21.1% | 19.61% |
Net Income | 63.06M | 70.51M | 56.63M | 163.26M | 194.48M | 229.91M | 214.16M | 131.64M |
Depreciation & Amortization | 53.1M | 67.5M | 112.68M | 109.29M | 115.84M | 167.63M | 287.51M | 298.38M |
Stock-Based Compensation | 8.15M | 10.8M | 67.53M | 77.48M | 69.74M | 79M | 38.78M | 63.28M |
Deferred Taxes | -800K | 203K | -1.15M | 14.54M | 36.66M | 24.22M | 26.05M | 12.54M |
Other Non-Cash Items | 5.56M | 27.89M | 67.23M | 45.94M | 22.59M | 43.49M | 114.45M | -240.47M |
Working Capital Changes | 20.44M | -41.51M | -29.44M | -74.99M | 37.9M | -29.38M | -37.28M | 249.47M |
Cash from Investing | -148M | -768.51M | -457.94M | -22.42M | -476.23M | -1.76B | -834.01M | -274.24M |
Capital Expenditures | -7.99M | -12.5M | -9.78M | -15.04M | -29.78M | -47M | -67.95M | -64.49M |
Acquisitions | -144.4M | -741.46M | -108.88M | 0 | -446.68M | -1.71B | -746.49M | -190.84M |
Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -16.56M | -16.64M |
Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing | 4.39M | -14.55M | -339.27M | -7.38M | 228K | 0 | -3.01M | -2.27M |
Cash from Financing | 62.27M | 1.13B | 429.28M | 314.76M | -12.61M | 1.17B | 78.12M | -172.44M |
Dividends Paid | -72.29M | -50.12M | -47.1M | -39.88M | -71.67M | -80.24M | -62.34M | -64.06M |
Share Repurchases | -3.17M | -52.56M | -967.85M | -7.17M | -8.79M | -27.46M | -3.73M | -41.01M |
Stock Issued | 0 | 0 | 1.45B | 0 | 0 | 0 | 0 | -164K |
Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | -3M |
Other Financing | 58.91M | 176.2M | 92.12M | -15.66M | 12.68M | -37.55M | 89.79M | 271.09M |
Net Change in Cash | 64.05M▲ 0% | 493.54M▲ 670.6% | 243.96M▼ 50.6% | 627.72M▲ 157.3% | -11.05M▼ 101.8% | -75.53M▼ 583.3% | -96.33M▼ 27.6% | 173.02M▲ 0% |
Exchange Rate Effect | 265K | 1.35M | -883K | -126K | 584K | -1.51M | 15.89M | 623K |
Cash at Beginning | 338.11M | 402.16M | 895.7M | 1.14B | 1.77B | 1.76B | 1.68B | 1.58B |
Cash at End | 402.16M | 895.7M | 1.14B | 1.77B | 1.76B | 1.68B | 1.58B | 1.48B |
Free Cash Flow | 141.52M▲ 0% | 122.89M▼ 13.2% | 263.71M▲ 114.6% | 320.47M▲ 21.5% | 447.43M▲ 39.6% | 467.87M▲ 4.6% | 575.71M▲ 23.1% | 554.59M▲ 0% |
FCF Growth % | - | -13.16% | 114.58% | 21.52% | 39.62% | 4.57% | 23.05% | 28.24% |
FCF Margin % | 18.5% | 12.07% | 18.41% | 18.58% | 21.54% | 18.6% | 18.87% | 17.57% |
FCF per Share | 1.33 | 1.15 | 2.49 | 1.21 | 3.56 | 1.7 | 2.07 | 4.28 |
RYAN Key Ratios
Ryan Specialty Holdings, Inc. (RYAN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Combined Ratio | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% | 79.51% | 83.43% |
Medical Cost Ratio | 0% | 0% | 0% | 0% | 0% | 9.42% | 30.55% |
Return on Equity (ROE) | 101.46% | 19.79% | 8.64% | 6.79% | 9.11% | 5.39% | 10.77% |
Return on Assets (ROA) | 2.03% | 1.32% | 1.03% | 0.9% | 1.12% | 0.63% | 1.25% |
Equity / Assets | 1.57% | 10.9% | 12.81% | 13.52% | 11.38% | 11.87% | 11.07% |
Book Value / Share | 0.67 | 5.63 | 3.08 | 7.79 | 4 | 4.5 | 9.41 |
Debt / Equity | 23.76x | 2.83x | 2.64x | 2.20x | 3.15x | 2.82x | 3.07x |
Revenue Growth | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% | 21.28% | 18.93% |
Related:RYAN Dividend History·RYAN Revenue History·RYAN Price History·RYAN P/E History·RYAN Financial Ratios·RYAN Institutional Holders
RYAN SEC Filings & Documents
Ryan Specialty Holdings, Inc. (RYAN) SEC filings — annual & quarterly reports (10-K, 10-Q)
RYAN Frequently Asked Questions
Ryan Specialty Holdings, Inc. (RYAN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Ryan Specialty Holdings, Inc. (RYAN) grew revenue by 21.3% over the past year. This is strong growth.
Yes, Ryan Specialty Holdings, Inc. (RYAN) is profitable, generating $131.6M in net income for fiscal year 2025 (2.1% net margin).
Dividend & Returns
Yes, Ryan Specialty Holdings, Inc. (RYAN) pays a dividend with a yield of 0.64%. This makes it attractive for income-focused investors.
Ryan Specialty Holdings, Inc. (RYAN) has a return on equity (ROE) of 5.4%. This is below average, suggesting room for improvement.
Industry Metrics
Ryan Specialty Holdings, Inc. (RYAN) has a combined ratio of 79.5%. A ratio below 100% indicates underwriting profitability.